Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
21%
OVERLAP
BY WEIGHT
8
# OF OVERLAPPING
HOLDINGS
HRTS
45
HOLDINGS
18%
ALSO IN OZEM
OZEM
21
HOLDINGS
38%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.9% | 15.8% | 12.9% |
 |
ASTRAZENECA PLC | 3.3% | 4.5% | 3.3% |
|
GILEAD SCIENCES INC | 3.2% | 2.1% | 2.1% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 1.0% | 5.1% | 1.0% |
|
AMGEN INC | 0.9% | 4.9% | 0.9% |
HRTS Overweight Relative to OZEM
|
THERMO FISHER SCIENTIFIC INC | 5.3% |
|
MERCK & CO. INC. | 4.5% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.4% |
|
KODIAK SCIENCES, INC. | 3.8% |
|
BRIDGEBIO PHARMA, INC. | 3.6% |
|
REVOLUTION MEDICINES, INC. | 3.6% |
|
UNITEDHEALTH GROUP INC | 3.4% |
|
JOHNSON & JOHNSON | 3.3% |
 |
NOVO NORDISK A/S-B | 3.3% |
|
NOVARTIS AG | 3.2% |
HRTS Underweight Relative to OZEM
|
NOVO-NORDISK A/S-SPONS ADR | -11.9% |
|
PFIZER INC | -8.4% |
|
KAILERA THERAPEUTICS INC | -5.9% |
 |
ASCLETIS PHARMA, INC. | -5.4% |
 |
CHINA PHARMACEUTICAL GROUP | -5.2% |
|
VIKING THERAPEUTICS, INC. | -4.2% |
|
CHUGAI PHARMACEUTICAL CO LTD | -4.1% |
|
AMGEN INC | -4.0% |
 |
HANMI PHARM CO LTD | -3.6% |
|
ZEALAND PHARMA A/S | -3.2% |